Background/Objectives: Cannabis sativa has been utilized for medical purposes for thousands of years.

Specific cannabinoids produced by the human body may help to quell excessive fear responses in people with post-traumatic stress disorder and anxiety, according to a Northwestern Medicine-led study published in the Journal of Clinical Investigation.

Any reduction in sleep time for people with clinical insomnia could be concerning.

Background and Objectives: Neuropsychiatric disorders pose a major global health challenge, marked by high prevalence, limited diagnostic precision, and suboptimal therapeutic outcomes.

Neurodegenerative diseases are a large and complex group of neurological disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, and so on, which adversely affect the physical and mental health of millions…

 A Lancet Psychiatry paper published this week — the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions — found no evidence that medicinal cannabis is effective in treating anxiety, depression or post…

Without causing a high.

A new review in Brain, Behavior, and Immunity challenges the idea that cannabis is strictly anti-inflammatory. Analyzing over 54,000 people, researchers found that regular cannabinoid use is linked to both pro- and anti-inflammatory immune responses.

Improved sleep and quality of life, reduced depression and anxiety

Nature Communications - ∆9-tetrahydrocannabinol induces anxiety at high doses, but the neural mechanisms remain unclear. Here, authors show that CB1 receptor–mediated inhibition of the...